1. The ecto-enzyme CD38 modulates CD4T cell immunometabolic responses and participates in HIV pathogenesis
- Author
-
Díaz-Basilio, Fernando, Vergara-Mendoza, Moisés, Romero-Rodríguez, Jessica, Hernández-Rizo, Sharik, Escobedo-Calvario, Alejandro, Fuentes-Romero, Luis-León, Pérez-Patrigeon, Santiago, Murakami-Ogasawara, Akio, Gomez-Palacio, María, Reyes-Terán, Gustavo, Jiang, Wei, Vázquez-Pérez, Joel-Armando, Marín-Hernández, Álvaro, Romero-Rodríguez, Dámaris-Priscila, Gutiérrez-Ruiz, María-Concepción, Viveros-Rogel, Mónica, and Espinosa, Enrique
- Abstract
Despite abundant evidence correlating T cell CD38 expression and HIV infection pathogenesis, its role as a CD4T cell immunometabolic regulator remains unclear. We find that CD38's extracellular glycohydrolase activity restricts metabolic reprogramming after T cell receptor (TCR)–engaging stimulation in Jurkat T CD4 cells, together with functional responses, while reducing intracellular nicotinamide adenine dinucleotide and nicotinamide mononucleotide concentrations. Selective elimination of CD38's ectoenzyme function licenses them to decrease the oxygen consumption rate/extracellular acidification rate ratio upon TCR signaling and to increase cycling, proliferation, survival, and CD40L induction. Pharmacological inhibition of ecto-CD38 catalytic activity in TMcells from chronic HIV-infected patients rescued TCR-triggered responses, including differentiation and effector functions, while reverting abnormally increased basal glycolysis, cycling, and spontaneous proinflammatory cytokine production. Additionally, ecto-CD38 blockage normalized basal and TCR-induced mitochondrial morphofunctionality, while increasing respiratory capacity in cells from HIV+patients and healthy individuals. Ectoenzyme CD38's immunometabolic restriction of TCR-involving stimulation is relevant to CD4T cell biology and to the deleterious effects of CD38 overexpression in HIV disease.CD38 catalytic activity contributes to CD4T cell dysfunction during HIV infection by dampening TCR-triggered metabolic, mitochondrial, and functional reprogramming.
- Published
- 2024
- Full Text
- View/download PDF